{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:49:53Z","timestamp":1726847393989},"reference-count":23,"publisher":"Wiley","issue":"s6","license":[{"start":{"date-parts":[[2008,9,29]],"date-time":"2008-09-29T00:00:00Z","timestamp":1222646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Haemophilia patients with inhibitors commonly present much more severe musculoskeletal problems than patients without inhibitors. With haematological advances using recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrate (aPCC), it is now possible to perform orthopaedic procedures in these patients with a high rate of success. In Spain, the healthcare system sets no financial limits for the treatment of haemophilia, and children with haemophilia today have a much better musculoskeletal status than 30\u2003years ago. However, the children of 30\u2003years ago are now adults and are afflicted by severe articular deformities that frequently require the intervention of an orthopaedic surgeon. Our view is that the well\u2010known concepts of prophylaxis in patients without inhibitors should be followed and applied to patients with inhibitors. In fact, prophylaxis seems to be the only way to prevent the development of haemophilic arthropathy in patients with haemophilia. Until this goal can be achieved, major and minor orthopaedic procedures will be necessary in patients with inhibitors more frequently than in patients without inhibitors.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01891.x","type":"journal-article","created":{"date-parts":[[2008,9,29]],"date-time":"2008-09-29T07:54:30Z","timestamp":1222674870000},"page":"56-67","source":"Crossref","is-referenced-by-count":11,"title":["Orthopaedic surgery in haemophilia patients with inhibitors as the last resort"],"prefix":"10.1111","volume":"14","author":[{"given":"E. C.","family":"RODRIGUEZ\u2010MERCHAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"QUINTANA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"JIMENEZ\u2010YUSTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,9,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00899.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01268.x"},{"issue":"2","key":"e_1_2_6_4_2","article-title":"Successful angiographic embolization of recurrent elbow joint bleeds in five patient with severe haemophilia A","volume":"5","author":"Klamroth R","year":"2007","journal-title":"J Thromb Haemost"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2001.00112.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.0050s1005.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00562.x"},{"issue":"2","key":"e_1_2_6_8_2","article-title":"Local intraarticular expression of factor IX from adeno\u2010associated virus (AAV) vectors prevents development of hemophilic arthropathy","volume":"5","author":"Sun J","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_9_2","article-title":"The impact of joint bleeding and synovitis on physical ability and joint function","volume":"5","author":"Valentino LA","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_10_2","article-title":"Needle induced haemarthrosis: a murine model of hemophilic synovitis","volume":"5","author":"Ovlisen K","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_11_2","article-title":"Factor IX concentrated in the joint space protects hemophilia B mice from bleeding\u2010induced joint deterioration in the absence of circulating factor IX","volume":"5","author":"Sun J","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_12_2","article-title":"Primary human synovial cells proliferate in response to hemoglobin and whole blood","volume":"5","author":"Valentino LA","year":"2007","journal-title":"J Thromb Haemost"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01520.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01267.x"},{"issue":"2","key":"e_1_2_6_15_2","article-title":"Secondary prophylaxis with recombinant activated factor VII (rFVIIa) in a severe haemophilia A patient with anti\u2010factor VIII inhibitors","volume":"5","author":"Marqu\u00e8s\u2010Verdier A","year":"2007","journal-title":"J Thromb Haemost"},{"key":"e_1_2_6_16_2","article-title":"Association between a history of inhibitors and delays in skeletal maturation in adolescent with hemophilia","volume":"5","author":"Donfield SM","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_17_2","article-title":"Radiosynoviorthesis is necessary in hemophilic patients despite prophylaxis","volume":"5","author":"Rodriguez\u2010Merchan EC","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_18_2","article-title":"Surgery in hemophilia patients with inhibitors: report of 91 surgical procedures","volume":"5","author":"Rodriguez\u2010Merchan EC","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"2","key":"e_1_2_6_19_2","article-title":"Primary knee arthroplasty using recombinant factor VIIa (rFVIIa) as first\u2010line therapy in haemophilia patients with high responding inhibitors","volume":"5","author":"Laurian YD","year":"2007","journal-title":"J Thromb Haemost"},{"key":"e_1_2_6_20_2","article-title":"Effective and safe long\u2010term prophylaxis in patients with high\u2010titer inhibitors using factor VIII inhibitor bypass activity (FEIBA)","author":"Kreuz W","year":"2001","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_21_2","article-title":"APCC (FEIBA) home treatment prophylaxis: an opportunity for inhibitor hemophilia A patients","author":"Centra M","year":"2001","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_22_2","first-page":"299","article-title":"Effective prophylaxis with daily rFVIIa (NovoSeven) in a child with high titer inhibitors and a target joint","volume":"6","author":"Saxon BR","year":"2000","journal-title":"Haemophilia"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01632.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01617.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01891.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01891.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T13:35:02Z","timestamp":1694612102000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01891.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,29]]},"references-count":23,"journal-issue":{"issue":"s6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01891.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01891.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,29]]}}}